Purification and mass spectrometric analysis of the κ opioid receptor

Brain Research

Volumn 1230, Issue , 2008, Pages 13-26

  Wannemacher, Kenneth M ^a   Terskiy, Alexandra ^a,b   Bian, Shengjie ^b,c   Yadav, Prem N ^b   Li, Hong ^a,b,c   Howells, Richard D ^a,b,d  

^a UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^c The State University of New Jersey   (United States)

^d NONE   (United States)

Author keywords

Chromatography; Cyanogen bromide; Mass spectrometry; Opioid; Receptor; Trypsin

Indexed keywords

DIPRENORPHINE; DYNORPHIN A; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); HEAT SHOCK PROTEIN 70; KAPPA OPIATE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; N DODECYL BETA DEXTRO MALTOPYRANOSIDE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; NALOXONE; PYRANOSIDE; UNCLASSIFIED DRUG; WHEAT GERM AGGLUTININ;

ARTICLE; GEL FILTRATION CHROMATOGRAPHY; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOBLOTTING; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PURIFICATION;

RATTUS; TRITICUM AESTIVUM;

EID: 54049156422     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2008.06.121     Document Type: Article

References (59)

1. Ablonczy, Z., Crouch, R.K., Knapp, D.R., 2005. Mass spectrometric analysis of integral membrane proteins at the subpicomolar level: applications to rhodopsin. J. Chromatogr. B. 825, 169-175.
2. Ancevska-Taneva, N., Onoprishvili, I., Andria, M.L., Hiller, J.M., Simon, E.J., 2006. A member of the heat shock protein 40 family, hlj1, binds to the carboxyl tail of the human mu opioid receptor. Brain Res. 1081, 28-33.
3. Appleyard, S.M., Celver, J., Pineda, V., Kovoor, A., Wayman, G.A., Chavkin, C., 1999. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin. J. Biol. Chem. 274, 23802-23807.
4. Appleyard, S.M., McLaughlin, J.P., Chavkin, C., 2000. Tyrosine phosphorylation of the κ-opioid receptor regulates agonist efficacy. J. Biol. Chem. 275, 38281-38285.
5. Ball, L.E., Oatis, J.E., Dharmasiri, K., Busman, M., Wang, J., Cowden, L.B., Galijatovic, A., Chen, N., Crouch, R.K., Knapp, D.R., 1998. Mass spectrometric analysis of integral membrane proteins: application to complete mapping of bacteriorhodopsins and rhodopsin. Protein Sci. 7, 758-764.
6. Chapple, J.P., Cheetham, M.E., 2003. The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation. J. Biol. Chem. 278, 19087-19094.
7. Chaturvedi, K., Christoffers, K.H., Singh, K., Howells, R.D., 2001a. Structure and regulation of opioid receptors. Biopolymers 55, 334-346.
8. Chaturvedi, K., Bandari, P., Chinen, N., Howells, R.D., 2001b. Proteasome involvement in agonist-induced down regulation of μ and δ opioid receptors. J. Biol. Chem. 276, 12345-12355.
9. Chen, Y., Chen, C., Wang, Y., Liu-Chen, L.Y., 2006. Ligands regulate cell surface level of the human κ opioid receptor by activation-induced down-regulation and pharmacological chaperone-mediated enhancement: differential effects of nonpeptide and peptide agonists. J. Pharmacol. Exp. Ther. 319, 765-775.
10. Chen, Y., Mestek, A., Liu, J., Hurley, J.A., Yu, L., 1993. Molecular cloning and functional expression of a mu-opioid receptor from rat brain. Mol. Pharmacol. 44, 8-12.
11. 50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
12. Cherezov, V., Rosenbaum, D.M., Hanson, M.A., Rasmussen, S.G., Thian, F.S., Kobilka, T.S., Choi, H.J., Kuhn, P., Weis, W.I., Kobilka, B.K., Stevens, R.C., 2007. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 318, 1258-1265.
13. Christoffers, K.H., Li, H., Keenan, S.M., Howells, R.D., 2003. Purification and mass spectrometric analysis of the μ opioid receptor. Mol. Brain Res. 118, 119-131.
14. Christoffers, K.H., Li, H., Howells, R.D., 2005. Purification and mass spectrometric analysis of the δ opioid receptor. Mol. Brain Res. 136, 54-64.
15. Choi, K.H., Basma, H., Singh, J., Cheng, P.W., 2005. Activation of CMV promoter-controlled glycosyltransferase and β-galactosidase glycogens by butyrate, trichostatin A, and 5-aza-2¢-deoxycytidine. Glycoconj. J. 22, 63-69.
16. Demand, J., Alberti, S., Patterson, C., Hohfeld, J., 2001. Cooperation of a ubiquitin domain protein and an E3 uiquitin ligase during chaperone/proteasome coupling. Curr. Biol. 11, 1569-1577.
17. Evans, C.J., Keith Jr., D.E., Morrison, H., Magendzo, K., Edwards, R.H., 1992. Cloning of a delta opioid receptor by functional expression. Science 258, 1952-1955.
18. Gioannini, T., Foucaud, B., Hiller, J.M., Hatten, M.E., Simon, E.J., 1982. Lectin binding of solubilized opiate receptors: evidence for their glycoprotein nature. Biochem. Biophys. Res Commun. 105, 1128-1134.
19. Itzhak, Y., Hiller, J.M., Simon, E.J., 1984. Solubilization and characterization of μ, δ, and κ opioid binding sites from guinea pig brain: physical separation of κ receptors. Proc. Natl. Acad. Sci. 81, 4217-4221.
20. Jaffe, J.H., Martin, W.R., 1990. Opioid analgesics and antagonists, In: Gilman, A.G., Rall, T.W., Nies, A.S., Taylor, P. (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. Pergamon Press, New York, pp. 485-521.
21. Jensen, O.N., 2004. Modification-specific proteomics: characterization of post-translational modifications by mass spectrometry. Curr. Opin. Chem. Biol. 8, 1-9.
22. Jeon, H.B., Choi, E.S., Yoon, J.H., Hwang, J.H., Chang, J.W., Lee, E.K., Choi, H.W., Park, Z., Yoo, Y.J., 2007. A proteomics approach to identify the ubiquitinated proteins in mouse heart. Biochem. Biophys. Res. Commun. 357, 731-736.
23. Kiang, J.G., Tsokos, G.C., 1998. Heat shock protein 70 kDa: molecular biology, biochemistry, and physiology. Pharmacol. Ther. 80, 183-201.
24. Kieffer, B.L., Befort, K., Gaveriaux-Ruff, C., Hirth, C., 1992. The delta-opioid receptor: isolation by a cDNA by expression cloning and pharmacological characterization. Proc. Natl. Acad. Sci. U. S. A. 89, 12048-12052.
25. Kraft, P., Mills, J., Dratz, E., 2001. Mass spectrometric analysis of cyanogen bromide fragments of integral membrane proteins at the picomole level: application to rhodopsin. Anal. Biochem. 292, 76-86.
26. 1 receptor. Biochem. Biophys. Res. Commun. 340, 395-402.
27. Land, B.B., Bruchas, M.R., Lemos, J.C., Xu, M., Melief, E.J., Chavkin, C., 2008. The dysphoric component of stress is encoded by activation of the dynorphin κ-opioid system. J. Neurosci. 28, 407-414.
28. Law, P.Y., Wong, Y.H., Loh, H.H., 2000. Molecular mechanisms and regulation of opioid receptor signaling. Annu. Rev. Pharmacol. Toxicol. 40, 389-430.
29. Li, J., Li, J.G., Chen, C., Zhang, F., Liu-Chen, L.Y., 2002. Molecular basis of differences in (-)(trans)-3,4-dichloro-N-methyl -N-[1-pyrrolidiny)-cyclohexyl]benzeneacetamide-induced desensitization and phosphorylation between human and rat κ-opioid receptors expressed in Chinese hamster ovary cells. Mol. Pharmacol. 61, 73-84.
30. Li, J.G., Benovic, J.L., Liu-Chen, L.Y., 2000. Mechanisms of agonist-induced down-regulation of the human kappa-opioid receptor: internalization is required for down-regulation. Mol. Pharmacol. 58, 795-801.
31. Li, J.G., Haines, D.S., Liu-Chen, L.Y., 2008. Agonist-promoted Lys 63-linked polyubiquitination of the human kappa opioid receptor is involved in receptor down-regulation. Mol. Pharmacol. 73, 1319-1330.
32. Liu-Chen, L.Y., 2004. Agonist-induced regulation and trafficking of κ opioid receptors. Life Sci. 75, 511-536.
33. Loacker, S., Mohammad, S., Wittmann, W., Herzog, H., Schwarzer, C., 2007. Endogenous dynorphin in epileptogenesis and epilepsy: anticonvulsant net effect via kappa opioid receptors. Brain 130, 1017-1028.
34. McLaughlin, J.P., Myers, L.C., Zarek, P.E., Caron, M.G., Lefkowitz, R.J., Czyzyk, T.A., Pintar, J.E., Chavkin, C., 2004. Prolonged kappa opioid receptor phosphorylation mediated by G-protein receptor kinase underlies sustained analgesic tolerance. J. Biol. Chem. 279, 1810-1818.
35. McLaughlin, J.P., Xu, M., Mackie, K., Chavkin, C., 2003. Phosphorylation of a carboxyl-terminal serine within the κ-opioid receptor produces desensitization and internalization. J. Biol. Chem. 278, 34631-34640.
36. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C.A., Motoshima, H., Fox, B.A., Le Trong, I., Teller, D.C., Okada, T., Stenkamp, R.E., Yamamoto, M., Miyano, M., 2000. Crystal structure of rhodopsin: a G protein-coupled receptor. Science 289, 739-745.
37. Peng, J., Schwartz, D., Elias, J.E., Thoreen, C.C., Cheng, D., Marsischky, G., Roelofs, J., Finley, D., Gygi, S.P., 2003. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21, 921-926.
38. Pert, C.B., Snyder, S.H., 1973. Opiate receptor: demonstration in nervous tissue. Science 179, 1011-1014.
39. Quach, T.T.T., Li, N., Richard, D.P., Zheng, J., Keller, B.O., Li, L., 2003. Development and applications of in-gel CNBr/tryptic digestion combined with mass spectrometry for the analysis of membrane proteins. J. Proteome Res. 2, 543-552.
40. Rasmussen, S.G., Choi, H.J., Rosenbaum, D.M., Kobilka, T.S., Thian, F.S., Edwards, P.C., Burghammer, M., Ratnala, V.R., Sanishvilli, R., Fischetti, R.F., Schertler, G.F., Weis, W.I., Kobilka, B.K., 2007. Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383-387.
41. Raynor, K., Kong, H., Chen, Y., Yasuda, K., Yu, L., Bell, G.I., Reisine, T., 1994. Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors. Mol. Pharmacol. 45, 330-334.
42. Riviere, P.J., 2004. Peripheral kappa-opioid agonists for visceral pain. Br. J. Pharmacol. 141, 1331-1334.
43. Shippenberg, T.S., Chefer, V.I., Zapata, A., Heidbreder, C.A., 2001. Modulation of the behavioral and neurochemical effects of psychostimulants by kappa-opioid receptor systems. Ann. N. Y. Acad. Sci. 937, 50-73.
44. Simon, E.J., Hiller, J.M., Edelman, I., 1973. Stereospecific binding of the potent narcotic analgesic (3H)-Etorphine to rat-brain homogenate. Proc. Natl. Acad. Sci. U. S. A. 70, 1947-1949.
45. Simon, J., Benyhe, S., Hepp, J., Varga, E., Medzihradszky, K., Borsodi, A., Wollemann, M., 1990. Method for isolation of kappa-opioid binding sites by dynorphin affinity chromatography. J. Neurosci. Res. 25, 549-555.
46. Smirnov, I.P., Zhu, X., Taylor, T., Huang, Y., Ross, P., Papayanopoulus, I.A., Martin, S.A., Pappin, D.J., 2004. Suppression of α-Cyano-4- hydroxycinnamic acid matrix clusters and reduction of chemical noise in MALDI-TOF mass spectrometry. Anal. Chem. 76, 2958-2965.
47. Tanowitz, M., von Zastrow, M., 2002. Ubiquitination-independent trafficking of G protein-coupled receptors to lysosomes. J. Biol. Chem. 277, 50219-50222.
48. Terenius, L., 1973. Stereospecific interaction between narcotic analgesics and a synaptic plasma membrane fraction of rat cerebral cortex. Acta Pharm. Toxicol. (Copenh). 32, 317-320.
49. Thompson, R.C., Mansour, A., Akil, H., Watson, S.J., 1993. Cloning and pharmacological characterization of a rat mu opioid receptor. Neuron 11, 903-913.
50. Trester-Zedlitz, M., Burlingame, A., Kobilka, B., von Zastrow, M., 2005. Mass spectrometric analysis of agonist effects on posttranslational modifications of the β-2 adrenoceptor in mammalian cells. Biochemistry 44, 6133-6143.
51. van Montfort, B.A., Doeven, M.K., Canas, B., Veenhoff, L.M., Poolman, B., Robillard, G.T., 2002. Combined in-gel tryptic digestion and CNBr cleavage for the generation of peptide maps of an integral membrane protein with MALDI-TOF mass spectrometry. Biochim. Biophys. Acta 1555, 111-115.
52. Wang, Z.J., Wang, L.X., 2006. Phosphorylation: a molecular switch in opioid tolerance. Life Sci. 79, 1681-1691.
53. Wannemacher, K.M., Yadav, P.N., Howells, R.D., 2007. A select set of opioid ligands induce up-regulation by promoting the maturation and stability of the rat kappa opioid receptor in human embryonic kidney 293 cells. J. Pharmacol. Exp. Ther. 323, 614-625.
54. Wilkins, M.R., Gasteiger, E., Gooley, A.A., Herbert, B.R., Molloy, M.P., Binz, P.A., Ou, K., Sanchez, J.C., Bairoch, A., Williams, K.L., Hochstrasser, D.F., 1999. High-throughput mass spectrometric discovery of protein post-translational modifications. J. Mol. Biol. 289, 645-657.
55. Williams, J.T., Christie, M.J., Manzoni, O., 2001. Cellular and synaptic adaptations mediating opioid dependence. Physiol. Rev. 81, 299-343.
56. Yadav, P.N., Chaturvedi, K., Howells, R.D., 2007. Inhibition of agonist-induced down-regulation of the δ-opioid receptor with a proteasome inhibitor attenuates opioid tolerance in human embryonic kidney 293 cells. J. Pharmacol. Exp. Ther. 320, 1186-1194.
57. Yasuda, K., Raynor, K., Kong, H., Breder, C.D., Takeda, J., Reisine, T., Bell, G.I., 1993. Cloning and functional comparison of kappa and delta opioid receptors from mouse brain. Proc. Natl. Acad. Sci. U. S. A. 90, 6736-6740.
58. Zhang, F., Li, J., Li, J.G., Liu-Chen, L.Y., 2002. (-)U50,488H [(trans)-3, 4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)- cyclohexyl] benzeneacetamide] induces internalization and down-regulation of the human, but not the rat, κ-opioid receptor: structural basis for the differential regulation. J. Pharmacol. Exp. Ther. 302, 1184-1192.
59. Zvonok, N., Yaddanapudi, S., Williams, J., Dai, S., Dong, K., Rejtar, T., Karger, B.L., Makriyannis, A., 2007. Comprehensive proteomic mass spectrometric characterization of human cannabinoid CB2 receptor. J. Proteome Res. 6, 2068-2079.